Skip to main content
. Author manuscript; available in PMC: 2015 Dec 30.
Published in final edited form as: J Neurooncol. 2015 Jun 13;124(2):307–316. doi: 10.1007/s11060-015-1841-y

Fig. 4.

Fig. 4

Effects of treatment and lymphocyte reinfusion on total lymphocyte counts. a Absolute total lymphocyte count (TLC) from baseline to the end of concurrent RT/TMZ (weeks 0–6); b TLC changes after lymphocyte reinfusion (weeks 6–20); c normalized TLC throughout the 20 weeks of prospective follow up, plotted individually for each patient in the study (normalized to baseline). d Total lymphocyte counts after lymphocyte reinfusion were not significantly different from matched historical controls; e CD4+ cell counts after lymphocyte reinfusion were not significantly different from matched historical controls asterisk denotes p value < 0.05. Triple asterisk denotes p value < 0.001